The University of Chicago Header Logo

Connection

Peter Sand to Aged, 80 and over

This is a "connection" page, showing publications Peter Sand has written about Aged, 80 and over.
Connection Strength

0.740
  1. Subjective and objective responses to PTNS and predictors for success: a retrospective cohort study of percutaneous tibial nerve stimulation for overactive bladder. Int Urogynecol J. 2019 08; 30(8):1253-1259.
    View in: PubMed
    Score: 0.075
  2. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013 Sep; 190(3):958-64.
    View in: PubMed
    Score: 0.050
  3. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged = 75 years) with overactive bladder syndrome. BJU Int. 2011 Feb; 107(4):612-20.
    View in: PubMed
    Score: 0.042
  4. Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul; 20(7):827-35.
    View in: PubMed
    Score: 0.038
  5. Predictors of persistent detrusor overactivity after transvaginal sling procedures. Am J Obstet Gynecol. 2008 Dec; 199(6):696.e1-7.
    View in: PubMed
    Score: 0.037
  6. Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction. Curr Med Res Opin. 2008 Aug; 24(8):2259-64.
    View in: PubMed
    Score: 0.036
  7. Cystoscopy for lower urinary tract symptoms in urogynecologic practice: the likelihood of finding bladder cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul; 19(7):991-4.
    View in: PubMed
    Score: 0.035
  8. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study. BJU Int. 2007 Apr; 99(4):836-44.
    View in: PubMed
    Score: 0.033
  9. Delivery mode is a major environmental determinant of stress urinary incontinence: results of the Evanston-Northwestern Twin Sisters Study. Am J Obstet Gynecol. 2005 Dec; 193(6):2149-53.
    View in: PubMed
    Score: 0.031
  10. Factors influencing the long-term success of periurethral collagen therapy in the office. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun; 17(4):346-51.
    View in: PubMed
    Score: 0.030
  11. Foley versus intermittent self-catheterization after transvaginal sling surgery: which works best? Urology. 2004 Jul; 64(1):53-7.
    View in: PubMed
    Score: 0.028
  12. Protective effect of suburethral slings on postoperative cystocele recurrence after reconstructive pelvic operation. Am J Obstet Gynecol. 2001 Dec; 185(6):1307-12; discussion 1312-3.
    View in: PubMed
    Score: 0.023
  13. Anterior or posterior sacrospinous vaginal vault suspension: long-term anatomic and functional evaluation. Obstet Gynecol. 2001 Aug; 98(2):199-204.
    View in: PubMed
    Score: 0.023
  14. Comparison of microtransducer and fiberoptic catheters for urodynamic studies. Obstet Gynecol. 2001 Aug; 98(2):253-7.
    View in: PubMed
    Score: 0.023
  15. Predictors of successful percutaneous tibial nerve stimulation (PTNS) in the treatment of overactive bladder syndrome. Int Urogynecol J. 2019 10; 30(10):1735-1745.
    View in: PubMed
    Score: 0.019
  16. Is There a Relationship Between Patient-Reported Satisfaction and Persistence on Overactive Bladder Syndrome Pharmacotherapy? Female Pelvic Med Reconstr Surg. 2018 May/Jun; 24(3):237-240.
    View in: PubMed
    Score: 0.018
  17. Pelvic floor stimulation in the treatment of mixed incontinence complicated by a low-pressure urethra. Obstet Gynecol. 1996 Nov; 88(5):757-60.
    View in: PubMed
    Score: 0.016
  18. Does physician specialty affect persistence to pharmacotherapy among patients with overactive bladder syndrome? Int Urogynecol J. 2017 Mar; 28(3):409-415.
    View in: PubMed
    Score: 0.016
  19. The empty supine stress test as a predictor of intrinsic urethral sphincter dysfunction. Obstet Gynecol. 1996 Jul; 88(1):128-32.
    View in: PubMed
    Score: 0.016
  20. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. Neurourol Urodyn. 2015 Jan; 34(1):37-43.
    View in: PubMed
    Score: 0.013
  21. Enhanced interpretability of the PFDI-20 with establishment of reference scores among women in the general population. Neurourol Urodyn. 2012 Nov; 31(8):1252-7.
    View in: PubMed
    Score: 0.012
  22. Simple standing incremental cystometry as a screening method for detrusor instability. Obstet Gynecol. 1991 Mar; 77(3):453-7.
    View in: PubMed
    Score: 0.011
  23. Nongenetic factors associated with stress urinary incontinence. Obstet Gynecol. 2011 Feb; 117(2 Pt 1):251-255.
    View in: PubMed
    Score: 0.011
  24. Urge incontinence: estimating environmental and obstetrical risk factors using an identical twin study. Int Urogynecol J. 2010 Aug; 21(8):939-46.
    View in: PubMed
    Score: 0.010
  25. Executive summary: The International Consultation on Incontinence 2008--Committee on: "Dynamic Testing"; for urinary or fecal incontinence. Part 2: Urodynamic testing in male patients with symptoms of urinary incontinence, in patients with relevant neurological abnormalities, and in children and in frail elderly with symptoms of urinary incontinence. Neurourol Urodyn. 2010; 29(1):146-52.
    View in: PubMed
    Score: 0.010
  26. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol. 2009 Apr; 181(4):1764-72.
    View in: PubMed
    Score: 0.010
  27. Impact of hysterectomy on stress urinary incontinence: an identical twin study. Am J Obstet Gynecol. 2008 May; 198(5):565.e1-4.
    View in: PubMed
    Score: 0.009
  28. Incontinence history as a predictor of detrusor stability. Obstet Gynecol. 1988 Feb; 71(2):257-60.
    View in: PubMed
    Score: 0.009
  29. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome. J Urol. 2007 Dec; 178(6):2488-94.
    View in: PubMed
    Score: 0.009
  30. Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials. Int Urol Nephrol. 2007; 39(4):1069-77.
    View in: PubMed
    Score: 0.008
  31. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Clin Ther. 2006 Nov; 28(11):1935-46.
    View in: PubMed
    Score: 0.008
  32. Risk factors for female anal incontinence: new insight through the Evanston-Northwestern twin sisters study. Obstet Gynecol. 2005 Oct; 106(4):726-32.
    View in: PubMed
    Score: 0.008
  33. Incidence of pubic osteomyelitis after bladder neck suspension using bone anchors. Urology. 2004 Apr; 63(4):704-8.
    View in: PubMed
    Score: 0.007
  34. Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study. Int Urol Nephrol. 2002; 34(1):43-9.
    View in: PubMed
    Score: 0.006
  35. Osteomyelitis of the pubis following suspension of the neck of the bladder with use of bone anchors. A report of four cases. J Bone Joint Surg Am. 1999 Dec; 81(12):1736-40.
    View in: PubMed
    Score: 0.005
  36. Extracorporeal magnetic innervation therapy for stress urinary incontinence. Urology. 1999 Jun; 53(6):1108-11.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.